Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Saliva based diagnostic test for eosinophilic oesophagitis

Resumen

Tipo:
Oferta Tecnológica
Referencia:
TOES20210204002
Publicado:
16/02/2021
Caducidad:
17/02/2022
Resumen:
A Spanish (Basque) scientific foundation specialized in R-Y-D and innovation management for healthcare systems seeks a company to license a method to analyse the diagnosis and/or prognosis of Eosinophilic Oesophagitis (EoE), using determination and quantification of certain salivary biomarkers.

Details

Tittle:
Saliva based diagnostic test for eosinophilic oesophagitis
Summary:
A Spanish (Basque) scientific foundation specialized in R-Y-D and innovation management for healthcare systems seeks a company to license a method to analyse the diagnosis and/or prognosis of Eosinophilic Oesophagitis (EoE), using determination and quantification of certain salivary biomarkers.
Description:
Eosinophilic Oesophagitis (EoE) is an inflammatory disease characterised by the presence of a large number of eosinophils (a variety of white blood cells) in the oesophagus.
The symptoms caused by EoE are variable, including diarrhoea or weight loss, and may be mistaken for other diseases (such as celiac disease). This may lead to diagnostic delays and difficulties.
EoE final diagnosis is currently achieved using invasive methods by means of upper gastrointestinal endoscopy and biopsies.
A rise in EoE incidence and prevalence is becoming a major cause of upper gastrointestinal morbidity in children and adults.
Delayed diagnosis seems associated with fibrostenotic disease complaints, suggesting timely recognition of the disease may impact its clinical course.
This invention provides a non-invasive method for selective testing of patients with higher risk of developing EoE, facilitating diagnostic processes, reducing the number of endoscopies, and enabling better management of patients.

The organization is offering a license agreement to experienced companies from the health sector interested in acquiring this technology. Although it is not compulsory, it would be preferable for the partner to be a healthcare facility so that the validation of the method can be carried out.
Advantages and Innovations:
The main advantage of this innovative diagnostic method is its non-invasiveness. No break in the skin is created and there is no contact with the mucosa, or skin break, or internal body cavity beyond a natural or artificial body orifice. Moreover, this method allows a quicker diagnosis of the disease compared to the traditional methods as upper endoscopy, biopsy or blood tests. Plus, it is cheaper in regard to those methods.
So, this new method offers a Selective diagnostic of Eosinophilic Oesophagitis (EoE), allowing a follow-up or prognosis of patients.
Stage of Development:
Under development/lab tested
IPs:
Patent(s) applied for but not yet granted
CommeR Statunts Regarding IPR Status:
Spanish Patent Application
Priority Date: 29/09/2020

Partner sought

Type and Role of Partner Sought:
The Spanish (Basque) organization is offering a license agreement to experienced companies in preclinical and clinical development of medical devices and diagnostic kits interested in acquiring this technology. Moreover, this license offer seeks both options: On the one side, companies willing to commercialise, but also companies interested in enhancing the invention.
It would be preferable for the partner to be a healthcare facility so that the validation of the method can be carried out. Nevertheless, this is not compulsory.

Client

Type and Size of Client:
R&D Institution
Already Engaged in Trans-National Cooperation:
No
Languages Spoken:
English
Spanish

Keywords

Technology Keywords:
06001005 Diagnósticos, diagnosis
06001002 Investigaciones clínicas, ensayos
06001012 Investigaciones médicas
06001013 Tecnología médica / ingeniería biomédica